Dergiler / Turkish Journal of Hematology / 2015 / Cilt: 32 - Sayı: 3

Allojenik Pediatrik Hematopoietik Kök Hücre Nakli Sonrasında Venöz Tromboembolizm: Bir Merkezin Deneyimi

Venous Thromboembolism after Allogeneic Pediatric Hematopoietic Stem Cell Transplantation: A Single-Center Study

Sayfa
228–233
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Kök hücre nakli öncesinde tüm hastalardan koagülasyon profili

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Hematopoetik kök hücre nakli (HSCT) yapılan hastalarda venöz tromboembolizm (VTE) yüksek morbiditeye sahiptir.
📊
Temel Bulgular & Veri:Bu çalışmanın amacı pediatrik allojenik HSCT alıcılarındaki VTE insidansını belirlemek ve pretransplant protrombotik risk faktörlerinin trombozdaki rolünü saptamaktır.Gereç ve Yöntemler:Nisan 2010-Kasım 2012 tarihleri arasında allojenik HSCT yapılan ve HSCT sonrası 100 gününü tamamlayan 92 hasta retrospektif olarak değerlendirildi.
💡
Sonuç & Katkı:Kök hücre nakli öncesinde tüm hastalardan koagülasyon profili
🔬Tür:Araştırma Makalesi
📍Kapsam:2010 · 92 hasta
⚙️Değişkenler:Alan Parametreleri

Özet

Hematopoetik kök hücre nakli (HSCT) yapılan hastalarda venöz tromboembolizm (VTE) yüksek morbiditeye sahiptir. Bu çalışmanın amacı pediatrik allojenik HSCT alıcılarındaki VTE insidansını belirlemek ve pretransplant protrombotik risk faktörlerinin trombozdaki rolünü saptamaktır.Gereç ve Yöntemler:Nisan 2010-Kasım 2012 tarihleri arasında allojenik HSCT yapılan ve HSCT sonrası 100 gününü tamamlayan 92 hasta retrospektif olarak değerlendirildi. Kök hücre nakli öncesinde tüm hastalardan koagülasyon profili

Abstract

Venous thromboembolism (VTE) in children who undergo hematopoietic stem cell transplantation (HSCT) has high morbidity. The aim of this study is to assess the incidence of VTE in allogeneic pediatric HSCT recipients and the contribution of pretransplant prothrombotic risk factors to thrombosis. Materials and Methods:We retrospectively evaluated 92 patients between April 2010 and November 2012 undergoing allogeneic HSCT who had completed 100 days post-HSCT. Before HSCT, coagulation profiles; acquired and inherited prothrombotic risk factors including FV G1691A (factor V Leiden), prothrombin G20210A, methylenetetrahydrofolate reductase (MTHFR) C677T, and MTHFR A1298C mutations; and serum homocysteine and lipoprotein (a), plasma antithrombin III, protein C, and protein S levels were obtained from all patients.Results:In the screening of thrombophilia, 8 patients (9%) were heterozygous for factor V Leiden, 5 (6%) were homozygous for MTHFR 677TT, 12 (14%) were homozygous for MTHFR 1298CC, and 2 (2%) were heterozygous for prothrombin G20210A mutation. We observed VTE in 5 patients (5.4%); a prothrombotic risk factor was found in 3 out of these 5 patients, while 4 out of 5 patients had central venous catheters. It was determined there was no significant relationship between VTE and inherited prothrombotic risk factors. Conclusion:VTE after HSCT seems to be a low-frequency event that may be due to low-dose, low-molecular-weight heparin prophylaxis, and the role of inherited prothrombotic risk factors cannot be entirely excluded without a prospective study

🔖

Bu Makaleye Atıf Yap

AZIK, F. M., GÖKÇEBAY, D. G., TAVİL, B., IŞIK, P., TUNÇ, B., UÇKAN, D. (2015). Allojenik Pediatrik Hematopoietik Kök Hücre Nakli Sonrasında Venöz Tromboembolizm: Bir Merkezin Deneyimi. Turkish Journal of Hematology, Cilt: 32 - Sayı: 3, 228–233. https://ajindex.com/articles/412820

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. Han Y, Zhu L, Sun A, Lu X, Hu L, Zhou L, Ren Y, Hu X, Wu X, Wang Z, Ruan C, Wu D. Alterations of hemostatic parameters in the early development of allogeneic hematopoietic stem cell transplantation-related complications. Ann Hematol 2011;90:1201-1208.
  2. Vannucchi AM, Rafanelli D, Longo G, Bosi A, Guidi S, Saccardi R, Filimberti E, Cinotti S, Grossi A, Morfini M, Rossi-Ferrini P. Early haemostatic alterations following bone marrow transplantation: a prospective study. Haematologica 1994;79:519-525.
  3. Harper PL, Jarvis J, Jennings I, Luddington R, Marcus RE. Changes in the natural anticoagulants following bone marrow transplantation. Bone Marrow Transplant 1990;5:39-42. Brandão LR, Kletzel M, Boulad F, Kurtzberg J, Maloney K, Fligman I, Sison CP, Dimichele D. A prospective longitudinal multicenter study of coagulation in pediatric patients undergoing allogeneic stem cell transplantation. Pediatr Blood Cancer 2008;50:1240- 1246. Hickman RO, Buckner DC, Clift RA, Sanders JE, Stewart P, Thomas ED. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979;148:871-875.
  4. McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, Hardin BJ, Shulman HM, Clift RA. Veno-occlusive disease of liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993;118:255-267.
  5. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood 1992;80:1998-2005.
  6. Ganji V, Kafai MR. Population references for plasma total homocysteine concentrations for US children and adolescents in the post-folic acid fortification era. J Nutr 2005;135:2253-2256.
  7. Wiznitzer M, Packer RJ, August CS, Burkey ED. Neurological complications of bone marrow transplantation in childhood. Ann Neurol 1984;16:569-576.
  8. Uderzo C, Marraro G, Riva A, Bonanomi E, Vaj PL, Marchi PF, Locasciulli A, Masera G. Pulmonary thromboembolism in leukemic children undergoing bone marrow transplantation. Bone Marrow Transplant 1993;11:201-203.
  9. Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998;133:770-776.
  10. Haire WD, Lieberman RP, Edney J, Vaughan WP, Kessinger A, Armitage JO, Goldsmith JC. Hickman catheter induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemother